
Johnson & Johnson Stock
Johnson & Johnson engages in the research and development, manufacture and sale of a range of products in the healthcare field.
Sign up today and learn more about Johnson & Johnson Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Johnson & Johnson Stock
Management
Postdoctoral Fellow
Jason Brown
Vice President, General Counsel
Michael H. Ullmann
Director, Worldwide Corporate Giving
Alice Lin Fabiano
Director of Product Lifecycle Management (PLM)
Reggie Fortson
IT Sr Manager, R&D IT PLM and Business Analyst
Kimberly Denman
VP, Director of the Global Content Lab
Carrie Sloan
Chief Development Officer Digital Surgery Group
Fred Moll, M.D
Sr. Director Consumer Scientific Innovation
Elena Fernandez Kleinlein
Senior Manager of Corporate Internal Audit
Aditya Misra
Senior Manager
Kenneth Turner
Press
BuzzFeed - Apr, 7 2020
Pelvic Mesh Victims Won Their Legal Fight Against Johnson & Johnson. Now The Pharmaceutical Giant Is Appealing.New York Times - Mar, 18 2020
Drug Companies Will Make a Killing From CoronavirusNew York Times - Mar, 12 2020
J. Seward Johnson Jr., Sculptor of the Hyper-Real, Dies at 89TechCrunch - Mar, 11 2020
Desperate to exit, a $10B price tag for Magic Leap is crazyForbes - Feb, 27 2020
Why Your Index Fund Is Built To Survive The Coronavirus OutbreakBuzzFeed - Feb, 11 2020
Pelvic Mesh Victims Waiting For Their Payout Say No Dollar Amount Will Be EnoughForbes - Jan, 2 2020
Firms Must Overcome Human Barriers to Enable Data-Driven TransformationNew York Times - Dec, 12 2019
Want a Bigger Say on Corporate Behavior? Move Your MoneyNew York Times - Dec, 3 2019
Labor Unions Team Up With Drug Makers to Defeat Drug-Price ProposalsForbes - Dec, 3 2019
Can Johnson & Johnson’s Stelara Become Number 2 Drug In Crohn’s Disease Market?BuzzFeed - Dec, 2 2019
Women In New Zealand Want To Sue Johnson & Johnson Over Mesh Implants. They Can’t.Forbes - Nov, 27 2019
Crisis Response: Start With The Three CsBuzzFeed - Nov, 21 2019
Hundreds Of Women Just Won A Landmark Case Against Johnson & Johnson Over Pelvic Mesh ImplantsForbes - Nov, 20 2019
Pfizer’s Xeljanz In the Crowded Rheumatoid Drugs MarketForbes - Nov, 15 2019
What’s Bristol-Myers Squibb’s Fair Stock Price Estimate Based On Expected 2019 Earnings?Forbes - Nov, 15 2019
Out-Of-Favor Drugs Stocks May Be The Right Medicine For Your PortfolioNew York Times - Nov, 7 2019
Making Drug Companies Pay for the Opioid EpidemicWall Streets Journal - Nov, 6 2019
AstraZeneca to Raise $1 Billion to Invest in China StartupsNew York Times - Oct, 31 2019
Say Hello to a New Auto GiantForbes - Oct, 31 2019
Johnson & Johnson: Quality At A Discount?New York Times - Oct, 29 2019
Johnson & Johnson Says Recalled Baby Powder Doesn’t Have AsbestosWall Streets Journal - Oct, 18 2019
Stocks Waver on China DataForbes - Oct, 18 2019
Wolves In Sheep’s Clothing: We Can’t Trust Businesses To Do Right By Americans NowForbes - Oct, 10 2019
7 Safe Dividend Aristocrats For Growing Retirement IncomeEquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase